Clariane SE (LON:0OPS)
3.624
-0.124 (-3.32%)
At close: Dec 12, 2025
Clariane SE Revenue
Clariane SE had revenue of 2.66B EUR in the half year ending June 30, 2025, with 8.23% growth. This brings the company's revenue in the last twelve months to 5.31B, up 2.70% year-over-year. In the year 2024, Clariane SE had annual revenue of 5.28B with 5.73% growth.
Revenue (ttm)
5.31B EUR
Revenue Growth
+2.70%
P/S Ratio
0.25
Revenue / Employee
85.92K EUR
Employees
61,798
Market Cap
1.12B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.28B | 286.17M | 5.73% |
| Dec 31, 2023 | 5.00B | 557.29M | 12.56% |
| Dec 31, 2022 | 4.44B | 300.99M | 7.27% |
| Dec 31, 2021 | 4.14B | 364.40M | 9.66% |
| Dec 31, 2020 | 3.77B | 160.41M | 4.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |